| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.60 | 0.08 | 0.00 | 0.00 | 0.07 |
| Long Term Debt-Equity Ratio | 0.15 | 0.05 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.15 | 2.54 | 2.86 | 2.73 | 1.84 |
| Fixed Assets | 1.05 | 1.43 | 1.63 | 1.57 | 1.64 |
| Inventory | 19.68 | 18.05 | 16.25 | 17.02 | 14.56 |
| Debtors | 6.51 | 7.31 | 9.67 | 8.71 | 9.42 |
| Interest Cover Ratio | 6.73 | 22.00 | 151.34 | 414.72 | 165.26 |
| PBIDTM (%) | 31.97 | 38.97 | 42.20 | 38.55 | 36.31 |
| PBITM (%) | 25.27 | 34.15 | 37.97 | 35.16 | 31.91 |
| PBDTM (%) | 28.22 | 37.42 | 41.95 | 38.47 | 36.12 |
| CPM (%) | 26.31 | 34.52 | 38.55 | 35.01 | 32.95 |
| APATM (%) | 19.61 | 29.69 | 34.32 | 31.62 | 28.55 |
| ROCE (%) | 9.98 | 19.94 | 25.68 | 26.48 | 24.21 |
| RONW (%) | 12.63 | 19.23 | 23.88 | 24.39 | 23.72 |